Maron B, Casey S, Olivotto I, Sherrid M, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters S, Giudici M, Koulova A, Garberich R, Rowin E, Sears S, Maron M, Spirito P. Clinical Course and Quality of Life in High Risk Patients with Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circulation: Arrhythmia and Electrophysiology 2018.
Koulova A, Gass AL, Patibandla S, Gupta CA, Aronow WS, Lanier GM. Management of Pulmonary Hypertension From Left Heart Disease In Candidates for Orthotopic Heart Transplantation. Journal of Thoracic Disease 2017.
Bavishi C, Koulova A, Bangalore S, Sawant A, Chatterjee S, Ather S, Valencia J, Sarafoff N, Rubboli A, Airaksinen JK, Lip GY, Tamis-Holland JE. Evaluation of the Efficacy and Safety of Dual Antiplatelet Therapy With or Without Warfarin in Patients With a Clinical Indication for DAPT and Chronic Anticoagulation: A Meta-Analysis of Observational Studies. Catheterization and Cardiovascular Interventions 2015 Sep 10.
Sherrid MV, Arabadjian M, Koulova A. Thin-Filament Mutations, Hypertrophic Cardiomyopathy and Risk. JACC: Journal of the American College of Cardiology 2014.
Anna Koulova, Shikha Broker, Tonusri Nag, David Payne, Julio A. Panza, Anthon Fuisz. Regional Variation in T1 Values by Cardiovascular Disease Process. Presented at: American College of Cardiology (ACC) Meeting, March 2019, in New Orleans, LA. Abstract: 14322.